Does rabbit anti-thymocyte globulin dose and antiviral prophylaxis alter the risk of the development of PTLD in renal transplant population?

Mahmoud Mohameda Nephrology Division, Department of Medicine;b University of Tennessee Health Science Center;c Memphis, TN, USACorrespondence[email protected]

Mohamed A. Ghonimd St. Jude Children’s Research Hospital, Memphis, TN, USA;e Department of Immunology, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt

Mai M. Abouzeidf Louisiana State University Health Sciences Center;g New Orleans, LA, USA

Maria Aurora Posadas Salash Division of Nephrology and Hypertension, Department of Medicine;i Medical University of South Carolina;j Charleston, SC, USA

References

Ali H, Soliman K, Daoud A, et al. Relationship between rabbit anti-thymocyte globulin and development of PTLD and its aggressive form in renal transplant population. Ren Fail. 2020;42(1):489–494.
PubMed Web of Science ®Google Scholar
Marks WH, Ilsley JN, Dharnidharka VR. Posttransplantation lymphoproliferative disorder in kidney and heart transplant recipients receiving thymoglobulin: a systematic review. Transplant Proc. 2011;43(5):1395–1404.
PubMed Web of Science ®Google Scholar
Laftavi MR, Alnimri M, Weber-Shrikant E, et al. Low-dose rabbit antithymocyte globulin versus basiliximab induction therapy in low-risk renal transplant recipients: 8-year follow-up. Transplant Proc. 2011;43(2):458–461.
PubMed Web of Science ®Google Scholar
Comak E, Akman S, Ongut G, et al. Epstein-Barr virus infection in children with renal transplantation: 17 years experience at a single center. Ren Fail. 2014;36(5):760–766.
PubMed Web of Science ®Google Scholar
Kute VB, Vanikar AV, Patel HV, et al. Outcome of renal transplantation from deceased donors: experience from developing country. Ren Fail. 2014;36(8):1215–1220.
PubMed Web of Science ®Google Scholar

Does rabbit anti-thymocyte globulin dose and antiviral prophylaxis alter the risk of the development of PTLD in renal transplant population?

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Does rabbit anti-thymocyte globulin dose and antiviral prophylaxis alter the risk of the development of PTLD in renal transplant population?

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date